Recent Updates
Recently added Catalysts
RVTY Positive Sentiment

Revvity Announces Financial Results for the Third Quarter of 2026

Tuesday, November 3, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Revvity, Inc. reported strong financial results for Q3 2026, with GAAP earnings per share rising to $0.56 from $0.41 year-over-year. Revenue increased to $729 million, up from $699 million in the same quarter last year. The company's operating income also saw an improvement, reaching $95 million compared to $82 million previously.

Market Sentiment Analysis

POSITIVE FACTORS

  • Earnings per share increased to $0.56.
  • Quarterly revenue rose to $729 million.
  • Operating income improved to $95 million.

Full Press Release Details

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today reported financial results for the third quarter ended October 4, 2026. The Company reported GAAP earnings per share from continuing operations of $0.56, as compared to $0.41 in the same period a year ago. Revenue for the quarter was $729 million, as compared to $699 million in the same period a year ago. GAAP operating income from continuing operations for the quarter was $95 million, as compared to $82 million for the same per

Frequently Asked Questions

What was Revvity's Q3 2026 EPS?

Revvity reported $0.56 GAAP EPS for Q3 2026.

How much revenue did Revvity report?

Revenue reached $729 million in the third quarter.

What was Q3 2026 operating income?

GAAP operating income was $95 million for the quarter.

How does Q3 2026 compare to prior year?

EPS rose from $0.41, while revenue grew from $699 million.

ShareAdd on Google
Tags: RVTY Revvity financial results Q3 2026 earnings report
Last updated: Nov 3, 2026

Biotech snapshot

Cash runway
$1023M liquidity · $0M/mo burn
Low dilution risk